Challenge
An early-stage biotech company with a promising technical platform was preparing to raise pre-seed funding but lacked a structured business roadmap, a clear go-to-market and pricing strategy, and alignment between its scientific development and investor expectations.
BioNext Approach
BioNext worked closely with the founding team to structure an investor-ready business plan, define a realistic development and funding roadmap, and refine the companyˇs strategic positioning within the competitive landscape. During this process, we identified critical gaps in several key activities required to support the companyˇs development strategy.
To address these gaps, BioNext helped identify and engage strategic partners capable of strengthening the companyˇs operational and technological capabilities. We also supported the negotiation and structuring of a collaboration agreement that significantly reinforced the robustness of the companyˇs business model and value proposition.
Outcome
The company strengthened its overall strategic positioning, secured a key collaboration with a strategic partner, and significantly increased the credibility and attractiveness of its investment case when approaching early-stage investors.